A palaeoecological approach to the last 21 000 years in the pyrenees: The peat bog of Freychinede (alt. 1350 m, Ariege, South France)

Local palaeoclimatic and palaeoecological reconstructions in the Ariège Pyrenees were applied to palynological and sedimentological investigations of the Freychinède peat bog (alt. 1350 m), complemented by a geomorphological study of the neighbouring area. Correlations are possible between local glacial evolution, deposition in the lake and the history of the vegetational cover for the period from about 21 300 B.P. to 13 000 B.P. The altitude of the cirque floors indicates mean July temperatures probably ranging between 6.5°C and 8.5°C from 21 300 B.P. to 15 000 B.P.; 7°C and 9°C from 15 000 B.P. to 13 150 B.P.; 7.5°C and 9.5°C from 13 150 B.P. to the beginning of the final transitional phase.

Based on the comparison of the palynological data with the modern plant communities of the area, especially with the subalpine and alpine communities, the local climate would have been favourable to the development of Boreo-arctic plants at the altitude of the lake during the cold phase.

The Postglacial period begins near 10 650 B.P. with the extension of Quercus. Abies spread at about 7000 B.P. followed by Tilia cordata. From 5000 to 3900 B.P., Fagus spread moderately, but its strongest development occurred after about 3900-3800 B.P., when human activity began on the mountain forest and many beech—fir forests developed. Middle Ages, in many valleys of Ariège, the mountain and subalpine forests were destroyed. The modern landscape has large treeless zones with scattered recent populations of beech where fir is beginning to develop.     

Bryophyte communities in mesotrophic fens in the Netherlands

Seven bryophyte and three vascular plant community types were described from eight small fens in the Vechtplassen area (prov. of Utrecht, the Netherlands). Clear relationships between the species composition of the bryophyte and vascular plant layer were found. The bryophyte species composition shows a gradual change from quaking fens dominated by Calliergon cordifolium to fens dominated by several species of Sphagnum . Fens dominated by C. cordifolium have relatively high pH and conductivity values and are strongly quaking, whereas fens dominated by Sphagnum have relatively low pH and conductivity values and the peat layer is continuous down to the bottom sediment. A comparison of the present-day vegetation with an earlier successional scheme for this vegetation type (Segal 1966) indicates a raise in nutrient levels and a decrease in the amount of seepage water welling up at the sites, both due to human activities. We suggest that in early successional phases bryophytes react faster to these changes, whereas in later phases vascular plants react faster.     

Imaging the invisible—Bioorthogonal Raman probes for imaging of cells and tissues

A revolutionary avenue for vibrational imaging with super‐multiplexing capability can be seen in the recent development of Raman‐active bioortogonal tags or labels. These tags and isotopic labels represent groups of chemically inert and small modifications, which can be introduced to any biomolecule of interest and then supplied to single cells or entire organisms. Recent developments in the field of spontaneous Raman spectroscopy and stimulated Raman spectroscopy in combination with targeted imaging of biomolecules within living systems are the main focus of this review. After having introduced common strategies for bioorthogonal labeling, we present applications thereof for profiling of resistance patterns in bacterial cells, investigations of pharmaceutical drug‐cell interactions in eukaryotic cells and cancer diagnosis in whole tissue samples. Ultimately, this approach proves to be a flexible and robust tool for in vivo imaging on several length scales and provides comparable information as fluorescence‐based imaging without the need of bulky fluorescent tags.     

Raman 18O-labeling of bacteria in visible and deep UV-ranges

Raman stable isotope labeling with ²H, ¹³C or ¹⁵N has been reported as an elegant approach to investigate cellular metabolic activity, which is of great importance to reveal the functions of microorganisms in native environments. A new strategy termed Raman ¹⁸O-labeling was developed to probe the metabolic activity of bacteria. Raman ¹⁸O-labeling refers to the combination of Raman microspectroscopy with ¹⁸O-labeling using H₂¹⁸O. At an excitation wavelength of 532 nm, the incorporation of ¹⁸O into the amide I group of proteins and DNA/RNA bases was observed in Escherichia coli cells, while for an excitation wavelength electronically resonant with DNA or aromatic amino acid absorption at 244 nm ¹⁸O assimilation was detected using chemometric tools rather than visual inspection. Raman ¹⁸O-labeling at 532 nm combined with 2D correlation analysis confirmed the assimilation of ¹⁸O in proteins and nucleic acids and revealed the growth strategy of E. coli cells; they underwent protein synthesis followed by nucleic acid synthesis. Independent cultural replicates at different incubation times corroborated the reproducibility of these results. The variations in spectral features of ¹⁸O-labeled cells revealed changes in physiological information of cells. Hence, Raman ¹⁸O-labeling could provide a powerful tool to identify metabolically active bacterial cells.     

Enhanced hydration of dipalmitoylphosphatidylcholine multibilayer by vinblastine sulphate

Vinblastine sulphate, an antimitotic and anti-inflammatory agent, modifies the thermal behaviour of the model membranes: the dipalmitoylphosphatidylcholine DPPC bilayers. The mixed DPPC and vinblastine sulphate multibilayers in the range of DPPC mole fraction 0.4 to 1 display clearly the gel-liquid crystal (chain melting) transition on the thermograms obtained with a differential scanning microcalorimeter. The molar enthalpy of this transition is slightly depressed by vinblastine sulphate (less than 10%). The temperature-composition phase diagram corresponds to a total insolubility of vinblastine sulphate inside the frozen (gel) bilayers and to a solubility of 0.2 (mole fraction) of vinblastine sulphate inside the fluid (liquid crystalline) bilayers. The dissolved vinblastine sulphate depresses the cooperativity number of the frozen ? fluid transition of the bilayers very strongly (4- to 5-times). Up to its solubility concentration, vinblastine sulphate increases the amount of the structural water of the bilayers and modifies the thermal behaviour of this water. The ‘expelled’ vinblastine sulphate molecules are retained by the polar groups of DPPC molecules and screen their electrostatic interactions with the structural water molecules. Below 0°C, the amount of the structural water, which forms the aqueous separation between two bilayers, is enhanced by vinblastine sulphate. However, the drug reduces (screens) the bilayers interaction with the structural water molecules.     

Effects of Buprenorphine,Chlorhexidine, and Low-level Laser Therapy on Wound Healing in Mice

Systemic buprenorphine and topical antiseptics such as chlorhexidine are frequently used in research animals to aid in pain control and to reduce infection, respectively. These therapeutics are controversial, especially when used in wound healing studies, due to conflicting data suggesting that they delay wound healing. Low-level laser therapy (LLLT) has been used to aid in wound healing without exerting the systemic effects of therapies such as buprenorphine. We conducted 2 studies to investigate the effects of these common treatment modalities on the rate of wound healing in mice. The first study used models of punch biopsy and dermal abrasion to assess whether buprenorphine HCl or 0.12% chlorhexidine delayed wound healing. The second study investigated the effects of sustained-released buprenorphine, 0.05% chlorhexidine, and LLLT on excisional wound healing. The rate of wound healing was assessed by obtaining photographs on days 0, 2, 4, 7, and 9 for the punch biopsy model in study 1, days 0, 1, 2, 4, 6, 8, 11, and 13 for the dermal abrasion model in study 1, and days 0, 3, 6, and 10 for the mice in study 2. Image J software was used to analyze the photographed wounds to determine the wound area. When comparing the wound area on the above days to the original wound area, no significant differences in healing were observed for any of the treatment groups at any time period for either study. Given the results of these studies, we believe that systemic buprenorphine, topical chlorhexidine, and LLLT can be used without impairing or delaying wound healing in mice.

A recent retrospective analysis using a medical insurance dataset estimated that approximately 8.2 million people experienced wounds ranging from acute to chronic conditions within the particular year analyzed, and estimated that the cost of acute and chronic wound treatments ranged from $28.1 to $96.8 billion dollars.⁵² The projected rise in the number of people experiencing wounds and the cost of wound care products⁵² have made wound healing a growing area of interest in both clinical medicine and research. Wound healing is a complex process that involves many overlapping, intricate physiologic processes. Each step can have associated deviations that may lead to enhanced, altered, impaired, or delayed healing. Animal research has been used to develop a better understanding of the basic, physiologic mechanisms of wound healing. Mice are the most commonly used animal in biomedical research, and they are used to model a host of conditions, including wound healing. Despite known anatomic and physiologic differences between murine and human skin,^17,53 this species is commonly used due to their small size, ease of handling, and relatively low cost. In addition, the overlapping phases of the wound healing process are similar in mice and humans, making mice a valuable model.⁶⁵Pain is inherent to the development of wound models. Pain receptors in the skin are sensitized during the actual wounding process and during the inflammatory response that occurs immediately after wounding.¹⁹ Pain can also occur during the cleansing and treatment of wounds.¹⁹ Just as managing wound pain is critical in human patients, The Guide for the Care and Use of Laboratory Animals (the Guide)³⁰ and other federal guidelines and regulations governing the care and use of laboratory animals strongly encourages the use of analgesics for animals that experience pain and/or distress.³⁰ Pain, which can also cause stress, may evoke a persistent catabolic state and may ultimately delay wound healing.^19,28,31,43 Therefore, adequate pain control is necessary to avoid negatively affecting or altering the wound healing process.As in human medicine, opioids are commonly used to provide analgesia to research rodents. Buprenorphine, a mixed agonist-antagonist opioid,^26,54 is a common analgesic that acts as a very weak partial agonist of the mu opioid receptor and an antagonist of the κ opioid receptor.²⁶ Buprenorphine is frequently used in animals as both a pre- and post-operative analgesic. It works by binding to the opioid receptors in the skin and other tissues. This ligand-receptor binding regulates the physiologic responses of nociception and inflammation,⁷ which are key factors in the process of healing and regeneration. Buprenorphine is often used instead of full mu-opioid receptor agonist drugs, such as morphine or hydromorphone, because it has fewer systemic side effects.²⁸ Despite their common use as analgesics, reports are mixed in terms of whether opioids, as a class, delay or impair wound healing.^11,28,35,40In addition to controlling pain, minimizing wound contamination and preventing infection is critical to wound healing. The use of antiseptics is often favored over the use of antibiotics as the former presents less chance for developing antibiotic resistance.⁶ As an antiseptic, chlorhexidine is commonly used to irrigate, cleanse, and treat cutaneous wounds. Chlorhexidine has high antimicrobial activity against gram-positive and gram-negative bacteria and some fungi and viruses.⁴ Although considered to be relatively safe, reports are conflicting with regard to whether chlorhexidine delays or impairs wound healing.^4,9,50,57Laser techniques have been used medically for many years, and their powerful, but precise capabilities have rendered them a unique surgical and therapeutic modality. In brief, when the electrons of atoms move to higher energy levels, these electrons absorb energy. This excited energy state is unstable and temporary. The natural return of electrons to their more stable ground state releases energy in the form of photons or light. Light Amplification by Stimulated Emission of Radiation (LASERS) are characterized by the photon stimulation of an already excited electron. This stimulation causes the emitted light to be amplified, as demonstrated by the intense, bright light that is emitted from lasers.⁶³ The concept of low-level laser therapy (LLLT) has garnered interest as a therapeutic modality in both human and veterinary medicine. Specifically characterized as laser therapy using a low power output and a low power range, LLLT is distinguished from other forms of laser therapies by certain parameters such as wavelength, pulse rate and duration, total irradiation time, and dose.⁴⁴ Although the mechanism of action for LLLT is not completely understood,^46,64 the absorption of red and near infrared light energy may reduce detrimental, inflammatory substances^13,15,24,56 while simultaneously stimulating restorative processes.^15,24,46,64 The reduced photothermal impact of LLLT⁴⁴ is reported to produce beneficial physiologic and biologic effects including analgesia, reduction in inflammation, and acceleration of healing.⁴⁸ The initial report of LLLT as a therapeutic modality found accelerated wound healing and fur regrowth in mice exposed to LLLT.^13,44,46,64 LLLT has since been used as a sole or adjunct therapy for a variety of conditions including tooth root resorption,⁵⁵ traumatic brain injuries,⁵⁸ and tendon, muscle, and bone injuries.^2,3,25,38Studies conducted to assess the effects of LLLT on healing often use parameters of normal wound healing to analyze how LLLT influences those parameters in comparison to healthy, undamaged tissue and damaged tissue not receiving laser therapy. Despite the numerous studies designed to investigate the effects of LLLT on wound healing, conflicting reports exist regarding its efficacy.^{15,17,46,22,23,24,29,34,38,39,55,56,60,64} A recent study in dogs reported accelerated healing and improved cosmetic appearance of a hemilaminectomy surgical site after LLLT,⁶⁰ while other canine studies reported no significant differences in the healing of surgically induced skin wounds between dogs that did and did not receive LLLT.^22,34 Similarly, in an attempt to study the effects of LLLT in pigs, an animal with skin very similar to that of humans, no significant differences were reported in the healing of surgically created skin wounds between swine that did and did not receive LLLT.²⁹ Studies using diabetic rats with excisional cutaneous wounds reported accelerated wound healing,^17,46 and beneficial results were reported in a similar study using diabetic mice.^56,64 While fewer studies have been conducted on the use of LLLT in rodents without concomitant comorbidities, LLLT has been reported to accelerate wound healing in healthy rodents.^15,24 Conversely, some studies found that LLLT does not accelerate or significantly improve wound healing in rodents.^24,39We performed 2 separate studies to investigate the effects of a commonly used opioid, a topical antiseptic solution, and LLLT on excisional wound healing in mice. At the time the initial study (study 1) was conducted, some of our investigators were reluctant to use the recommended analgesic, buprenorphine, due to concern about interference with their study outcomes. Therefore, we conducted study 1 to determine if a single dose of peri-operative buprenorphine would delay healing of a full-thickness excisional wound or a partial-thickness felt wheel dermal abrasion. We also examined the effects of topical chlorhexidine solution on wound healing. The chlorhexidine concentrations used in study 1 were prepared using our standard operating procedure at that time. Study 2 was conducted after study 1, with the design expanded to evaluate a sustained release buprenorphine formulation and LLLT. Study 2 used a full-thickness excisional biopsy to determine the effect of LLLT on excisional wound healing. Commonly used doses of systemic Buprenorphine Sustained Release (SR) and topical chlorhexidine were also included to evaluate their effect on excisional wound healing. The concentration of chlorhexidine in the revised, approved standard operating procedure had been decreased due to literature suggesting that higher concentrations may inhibit healing.^4,49,61 For both studies, we hypothesized that the use of buprenorphine and chlorhexidine would have no effect on the rate of wound healing, and that LLLT would accelerate wound healing in a full-thickness excision as compared with a control.